Insud Pharma
Esteban Gergic has a strong background in pharmaceutical R&D. Esteban started their career at Laboratorios Beta S.A. in 2000 as a Supervisor in R&D Formulation Development. From there, they worked at IVAX Argentina - Teva Group Member as a Team Leader responsible for R&D and Tech Transfer. Esteban then joined Valeant Pharmaceuticals as the Head of R&D Technical Support. After that, they worked at HLB Pharma as the Head of R&D Pharmaceutical Development. Esteban then moved to Laboratorio LKM S.A. as the Manager of R&D Formulation Development. In 2012, they joined Laboratorios Beta S.A. again, but this time as the Head of R&D Formulation Development. In 2015, they joined Insud Pharma as the Manager of R&D Solids, and later took on roles as R&D Associate Director and Tech Transfer & Development Director. Currently, they are the FARMA R&D Director at Insud Pharma, leading the global R&D organization for finished dosage forms.
Esteban Gergic attended IESE Business School from 2016 to 2017, completing the Corporate Development Program. Prior to that, from 1998 to 2005, they studied at the University of Buenos Aires, earning a degree in Farmacia.
This person is not in the org chart
This person is not in any teams
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.